Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.

Not Applicable

Not yet recruiting

• Conditions: Epilepsy

• Registration Number: NCT06898749
• Lead Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Brief Summary

In addition to the search for new pharmaceutical or surgical solutions that could improve the therapeutic management of epileptic individuals, it is interesting to ask whether other complementary approaches, such as canine mediation in psychomotor therapy, could enhance the quality of life in this population.

However, there is currently no evidence indicating that exposure to animals through mediation sessions would be beneficial for epileptic individuals, particularly regarding their quality of life, anxiety, emotional management, or cognition (such as social cognition). In the absence of current data in this population, it seems pertinent to study the impact of this practice on people with epilepsy. Furthermore, beyond quality of life, it would be valuable to examine whether it also influences anxiety or the frequency of seizures in individuals with epilepsy (a phenomenon reported for epileptic individuals living with a pet dog or a service dog). Canine mediation could help better manage and regulate the emotions of epileptic individuals, as well as improve their self-esteem.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-03
• Study First Submitted: 2025-03-21
• Study First Submitted QC: 2025-03-21
• Study First Posted: 2025-03-27
• Last Update Submitted: 2025-03-31
• Last Update Posted: 2025-04-03
• Study Start: 2025-06
• Primary Completion: 2028-12
• Study Completion: 2028-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

• Person aged ≥ 18 years
• Presenting pharmacoresistant epilepsy according to the criteria of the International League Against Epilepsy
• Requiring psychomotor therapy sessions for one of the following indications:

Difficult emotional and relational management And/or global motor difficulties And/or body schema organization disorder And/or temporo-spatial disorder

• Explicit consent or no opposition to participation in the study by the patient and/or their legal representative or guardian
• Image rights consented by the patient and their legal representative or guardian, if applicable
• Hospitalization or residence at the Teppe Institute or at the FAM (Foyer d'Accueil Médicalisé) des 4 Jardins planned for at least 3 months
• Affiliated with or a beneficiary of a social security scheme

Exclusion Criteria

• Fear or phobia of dogs
• Epileptic person benefiting from a legal protection measure other than guardianship or curatorship
• Person with insufficient cognitive abilities to respond to the questionnaires
• Pregnant or breastfeeding woman

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Improvement of quality of life	Day 0 and Day 7 after the end of the 10 sessions	Increase in the Quality of Life in Epilepsy Inventory-31 (QOLIE-31) score of at least 5 points between inclusion and one week after the completion of the 10 sessions.; The score of the QOLIE-31 (Quality of Life in Epilepsy Inventory-31) ranges from 0 to 100. A score of 0 represents the worst possible quality of life, while a score of 100 represents the best possible quality of life.